Nurix Therapeutics, Inc. (NRIX)
22.16
-0.19
(-0.85%)
USD |
NASDAQ |
Oct 12, 16:00
22.55
+0.39
(+1.76%)
After-Hours: 04:45
Nurix Therapeutics Total Assets (Quarterly) : 1.195B for Aug. 31, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2026 | 1.195B |
| May 31, 2026 | 535.54M |
| February 28, 2026 | 636.13M |
| November 30, 2025 | 702.56M |
| August 31, 2025 | 522.47M |
| May 31, 2025 | 591.56M |
| February 28, 2025 | 615.04M |
| November 30, 2024 | 675.43M |
| August 31, 2024 | 513.60M |
| May 31, 2024 | 511.03M |
| February 29, 2024 | 312.67M |
| November 30, 2023 | 364.54M |
| August 31, 2023 | 308.20M |
| May 31, 2023 | 350.62M |
| Date | Value |
|---|---|
| February 28, 2023 | 370.15M |
| November 30, 2022 | 420.06M |
| August 31, 2022 | 459.34M |
| May 31, 2022 | 394.31M |
| February 28, 2022 | 437.72M |
| November 30, 2021 | 480.10M |
| August 31, 2021 | 493.07M |
| May 31, 2021 | 517.98M |
| February 28, 2021 | 396.66M |
| November 30, 2020 | 396.34M |
| August 31, 2020 | 411.87M |
| May 31, 2020 | 213.28M |
| February 29, 2020 | 88.79M |
| November 30, 2019 | 44.05M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 49.36B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 226.99M |
| Shareholders Equity (Quarterly) | 968.31M |
| Debt to Equity Ratio | 0.0675 |
| Current Ratio | 8.442 |
| Net Debt Paydown Yield | -0.10% |